NEUREXPERT Trademark

Trademark Overview


On Wednesday, June 3, 2015, a trademark application was filed for NEUREXPERT with the United States Patent and Trademark Office. The USPTO has given the NEUREXPERT trademark a serial number of 86650167. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Thursday, February 16, 2023. This trademark is owned by Neurexpert Ltd.. The NEUREXPERT trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific and technological services and research and design relating thereto, namely, testing, screening and analysis of pharmaceuticals and naturally occurring substances, chemical screening and analysis, testing, screening and analysis of biological substances, performing pharmaceutical screening assays for others, evaluation of mechanisms of action of pharmaceuticals and naturally occurring substances, and identification of changes in biological functions in models of disease; scientific analysis and research services, namely, testing, screening and analysis of pharmaceuticals and naturally occurring substances, chemical screening and analysis, testing, screening and analysis of biological substances, performing pharmaceutical screening assays for others, evaluation of mechanisms of action of pharmaceuticals and naturally occurring substances, and identification of changes in biological functions in models of disease; scientific analysis and research services using cell cultures a...
neurexpert

General Information


Serial Number86650167
Word MarkNEUREXPERT
Filing DateWednesday, June 3, 2015
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateThursday, February 16, 2023
Registration Number5010851
Registration DateTuesday, August 2, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 17, 2016

Trademark Statements


Goods and ServicesScientific and technological services and research and design relating thereto, namely, testing, screening and analysis of pharmaceuticals and naturally occurring substances, chemical screening and analysis, testing, screening and analysis of biological substances, performing pharmaceutical screening assays for others, evaluation of mechanisms of action of pharmaceuticals and naturally occurring substances, and identification of changes in biological functions in models of disease; scientific analysis and research services, namely, testing, screening and analysis of pharmaceuticals and naturally occurring substances, chemical screening and analysis, testing, screening and analysis of biological substances, performing pharmaceutical screening assays for others, evaluation of mechanisms of action of pharmaceuticals and naturally occurring substances, and identification of changes in biological functions in models of disease; scientific analysis and research services using cell cultures and/or stem cells to define the action of novel therapeutics in the central nervous system, namely, testing, screening and analysis of pharmaceuticals and naturally occurring substances, chemical screening and analysis, testing, screening and analysis of biological substances, performing pharmaceutical screening assays for others, evaluation of mechanisms of action of pharmaceuticals and naturally occurring substances, and identification of changes in biological functions in models of disease; scientific laboratory, analysis and research services for electrophysiology and related techniques to define the action of novel therapeutics in the central nervous system, namely, testing, screening and analysis of pharmaceuticals and naturally occurring substances, chemical screening and analysis, testing, screening and analysis of biological substances, performing pharmaceutical screening assays for others, evaluation of mechanisms of action of pharmaceuticals and naturally occurring substances, and identification of changes in biological functions in models of disease; scientific laboratory, analysis and research services providing data on biological, organic and non-organic chemical potency, efficacy and mechanism of action at a native biological target in the central nervous system, namely, testing, screening and analysis of pharmaceuticals and naturally occurring substances, chemical screening and analysis, testing, screening and analysis of biological substances, performing pharmaceutical screening assays for others, evaluation of mechanisms of action of pharmaceuticals and naturally occurring substances, and identification of changes in biological functions in models of disease; scientific laboratory, analysis and research services measuring biological, organic and non-organic chemical compound potency against biological targets coupled to their native transduction pathways and expressed with their naturally occurring subunit conformation and accessory proteins in the central nervous system, namely, testing, screening and analysis of pharmaceuticals and naturally occurring substances, chemical screening and analysis, testing, screening and analysis of biological substances, performing pharmaceutical screening assays for others, evaluation of mechanisms of action of pharmaceuticals and naturally occurring substances, and identification of changes in biological functions in models of disease; scientific laboratory, analysis and research services providing functional and mechanistic data on neural mechanisms that underlie higher brain functions, such as cognition, attention and sensory processing, namely, testing, screening and analysis of pharmaceuticals and naturally occurring substances, chemical screening and analysis, testing, screening and analysis of biological substances, performing pharmaceutical screening assays for others, evaluation of mechanisms of action of pharmaceuticals and naturally occurring substances, and identification of changes in biological functions in models of disease; scientific laboratory, analysis and research services to define the phenotype of transgenic models at the cellular and neuronal network level, namely, testing, screening and analysis of pharmaceuticals and naturally occurring substances, chemical screening and analysis, testing, screening and analysis of biological substances, performing pharmaceutical screening assays for others, evaluation of mechanisms of action of pharmaceuticals and naturally occurring substances, and identification of changes in biological functions in models of disease; scientific laboratory, analysis and research services to produce functional and mechanistic data on the physiological processes that may be affected in central nervous system disorders, such as the mechanisms underlying learning, memory, attention and sensory processing, namely, testing, screening and analysis of pharmaceuticals and naturally occurring substances, chemical screening and analysis, testing, screening and analysis of biological substances, performing pharmaceutical screening assays for others, evaluation of mechanisms of action of pharmaceuticals and naturally occurring substances, and identification of changes in biological functions in models of disease; scientific laboratory, analysis and research services for the provision of scientific functional and mechanistic data on neurophysiological diseases, including psychiatry, neurology, neurodegeneration, epilepsy, pain, ophthalmology and retinal neurodegeneration, namely, testing, screening and analysis of pharmaceuticals and naturally occurring substances, chemical screening and analysis, testing, screening and analysis of biological substances, performing pharmaceutical screening assays for others, evaluation of mechanisms of action of pharmaceuticals and naturally occurring substances, and identification of changes in biological functions in models of disease; scientific laboratory, analysis and research services for the provision of scientific functional and mechanistic data on biological targets, including ligand and voltage gated ion channels, G-protein coupled receptors and biological transporters, namely, testing, screening and analysis of pharmaceuticals and naturally occurring substances, chemical screening and analysis, testing, screening and analysis of biological substances, performing pharmaceutical screening assays for others, evaluation of mechanisms of action of pharmaceuticals and naturally occurring substances, and identification of changes in biological functions in models of disease; scientific laboratory services to discover and research the biological site of action of novel therapeutics within a cellular and neuronal network, namely, testing, screening and analysis of pharmaceuticals and naturally occurring substances, chemical screening and analysis, testing, screening and analysis of biological substances, performing pharmaceutical screening assays for others, evaluation of mechanisms of action of pharmaceuticals and naturally occurring substances, and identification of changes in biological functions in models of disease; design and development of assays using cell cultures and/or stem cells, namely, testing, screening and analysis of pharmaceuticals and naturally occurring substances, chemical screening and analysis, testing, screening and analysis of biological substances, performing pharmaceutical screening assays for others, evaluation of mechanisms of action of pharmaceuticals and naturally occurring substances, and identification of changes in biological functions in models of disease; design and development of electrophysiology and electrophysiological assays, namely, testing, screening and analysis of pharmaceuticals and naturally occurring substances, chemical screening and analysis, testing, screening and analysis of biological substances, performing pharmaceutical screening assays for others, evaluation of mechanisms of action of pharmaceuticals and naturally occurring substances, and identification of changes in biological functions in models of disease; design and development of laboratory equipment assays using cell cultures and/or stem cells and laboratory consumables therefor, namely, for testing, screening and analysis of pharmaceuticals and naturally occurring substances, chemical screening and analysis, testing, screening and analysis of biological substances, performing pharmaceutical screening assays for others, evaluation of mechanisms of action of pharmaceuticals and naturally occurring substances, and identification of changes in biological functions in models of disease; design and development of laboratory equipment for electrophysiology and electrophysiological assays and laboratory consumables therefor, namely, testing, screening and analysis of pharmaceuticals and naturally occurring substances, chemical screening and analysis, testing, screening and analysis of biological substances, performing pharmaceutical screening assays for others, evaluation of mechanisms of action of pharmaceuticals and naturally occurring substances, and identification of changes in biological functions in models of disease; scientific research consulting in the field of assays using and/or including cell cultures and/or stem cells; scientific research consulting in the field of electrophysiology and electrophysiological assays; scientific research consulting in the field of neurophysiology and neuropharmacology; scientific research consulting in the field of educational and research project progression for all stages of the drug discovery process; scientific research consulting in the field of educational and research study plans in the field of neurophysiology and neuropharmacology; scientific research consulting in the field of analysis and interpretation of experimental findings in the field of neurophysiology and neuropharmacology; scientific research consulting in the field of the establishment and setting up of new laboratories; scientific research consulting in the field of the establishment and setting up of new laboratories using and/or including cell cultures and/or stem cells; scientific research consulting in the field of the establishment and setting up of new electrophysiology laboratories; scientific research consulting in the field of the design and development of assays for diseases and biological targets in the field of neurophysiology and neuropharmacology; scientific research consulting in the field of the preparation of data for the pharmaceutical industry; scientific research consulting in the field of the preparation of data for the pharmaceutical industry generated from cell cultures and/or stem cells; scientific research consulting in the field of the preparation of electrophysiological data for the pharmaceutical industry; scientific research consulting in the field of the design and development of assays for drug discovery; scientific research consulting in the field of the design and development of assays using and/or including cell cultures and/or stem cells for drug discovery; scientific research consulting in the field of the design and development of electrophysiology assays for drug discovery; scientific research consulting in the field of assays and tests to aid preclinical and clinical drug discovery programs, project progression, experimental plans and interpretation of data; scientific research consulting in the field of assays and tests using and/or including cell cultures and/or stem cells to aid preclinical and clinical drug discovery programs, project progression, experimental plans and interpretation of data; scientific research consulting in the field of electrophysiology and electrophysiological assays and tests to aid preclinical and clinical drug discovery programs, project progression, experimental plans and interpretation of data; scientific research consulting in the field of equipment purchase, and design and assembly of laboratories for in vitro and in vivo assays and tests; scientific research consulting in the field of equipment purchase, and design and assembly of laboratories using and/or including cell cultures and/or stem cells for in vitro assays and tests; scientific research consulting in the field of equipment purchase, and design and assembly of electrophysiology laboratories for in vitro and in vivo assays and tests; scientific research technology consulting services to the pharmaceutical industry on clinical and preclinical research in the fields of electrophysiology, neurophysiology and neuropharmacology; scientific research consulting services in neuroscience and translational research for disorders including neurology, neurodegeneration, psychiatry, epilepsy, pain and ophthalmology; scientific research technology consulting services providing guidance and experimental support for drug discovery research from target identification and validation through to candidate selection and progression to the clinic; scientific research consulting services on all applications of electrophysiology, including safety testing, drug screening, automated platforms and development of functional biomarkers

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, June 9, 2015
Primary Code042
First Use Anywhere DateSunday, June 30, 2013
First Use In Commerce DateSunday, June 30, 2013

Trademark Owner History


Party NameNeurexpert Ltd.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressNewcastle Upon Tyne NE4 5TF
GB

Party NameNeurexpert Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressLondon EC1V2NX
GB

Party NameNeurexpert Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLondon EC1V2NX
GB

Trademark Events


Event DateEvent Description
Thursday, February 16, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, February 16, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, February 16, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, August 1, 2022TEAS SECTION 8 & 15 RECEIVED
Monday, August 2, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, August 2, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, May 17, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 17, 2016PUBLISHED FOR OPPOSITION
Wednesday, April 27, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, April 13, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, April 5, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, March 12, 2016DATA MODIFICATION COMPLETED
Friday, March 11, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 11, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 3, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 22, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 22, 2015NON-FINAL ACTION E-MAILED
Tuesday, September 22, 2015NON-FINAL ACTION WRITTEN
Tuesday, September 15, 2015DATA MODIFICATION COMPLETED
Tuesday, September 15, 2015ASSIGNED TO LIE
Tuesday, September 15, 2015ASSIGNED TO EXAMINER
Tuesday, June 9, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, June 6, 2015NEW APPLICATION ENTERED